Complications of Pregnancy in Myotonic Dystrophy Nicholas Johnson

  • Slides: 14
Download presentation
Complications of Pregnancy in Myotonic Dystrophy Nicholas Johnson, MD Assistant Professor of Neurology, Pediatrics,

Complications of Pregnancy in Myotonic Dystrophy Nicholas Johnson, MD Assistant Professor of Neurology, Pediatrics, Pathology University of Utah On behalf of: JD Franklin, E Nasser, E Luebbe, J Hilbert, KA Hagerman, JW Day, E Ciafaloni, M Hung, CR Heatwole

Background • Myotonic Dystrophies are multisystemic disorders due to a CTG repeat (DM 1)

Background • Myotonic Dystrophies are multisystemic disorders due to a CTG repeat (DM 1) or CCTG repeat (DM 2) • Prior reports of pregnancy complications include: – DM 1: • abortions, polyhydramnios, ectopic pregnancy, placenta previa, preterm labor – DM 2: • preterm labor

Methods • Survey included demographics, obstetrical history, and Myotonic Dystrophy Health Index Short Form

Methods • Survey included demographics, obstetrical history, and Myotonic Dystrophy Health Index Short Form (MDHI-SF) • Measured QOL prior, during, and after 1 st pregnancy with: – Overall MDHI-SF score – Impact score (mean Likert x prevalence) • Distributed to DM 1 and DM 2 women between the ages of 18 -50 through the NIH Registry and MDF Patient Registry

Results: Demographics • • 151 women responded (39. 7%) Mean age 38. 7 (SD

Results: Demographics • • 151 women responded (39. 7%) Mean age 38. 7 (SD 6. 9) Disease duration 14. 4 years (9. 5) 70. 6% have DM 1 – CTG repeat length 330. 5 (SD 222. 5) • 19. 3% have DM 2 – CCTG repeat length 12414. 3 (7299. 0) • 388 pregnancies

Assistive Reproductive Technology Use Item 1 st pregnancy 2 nd pregnancy and greater Maternal

Assistive Reproductive Technology Use Item 1 st pregnancy 2 nd pregnancy and greater Maternal Age 27. 6 (SD 5. 5) 30. 7 (SD 4. 6) Assistive Technology In-vitro fertilization 17. 2% 3. 9% Hormone therapy 10% 1. 4% Pre-implantation diagnosis 6. 6% 1. 9%

Pregnancy Complications in DM 1 and DM 2 Complications 1 st pregnancy 2 nd

Pregnancy Complications in DM 1 and DM 2 Complications 1 st pregnancy 2 nd pregnancy and greater Pre-eclampsia (%) 11. 9 2. 0 Low birth weight (%) 16. 5 2. 3 Polyhydramnios (%) 19. 2 2. 8 Pre-term labor (%) 26. 5 2. 8 Miscarriage (%) 3. 9 2. 0 Stillbirth (%) 3. 3 0. 3 Peripartum hemorrhage (%) 13. 2 2. 2 Infection (%) 1. 3 . 8 None (%) 40. 4 10. 5 Mean gestational age 36. 4 (SD 6. 3) 37. 1 (SD 5. 1)

1 st Pregnancy Complications (DM 1 and DM 2 specific) Complications Mothers with DM

1 st Pregnancy Complications (DM 1 and DM 2 specific) Complications Mothers with DM 1 Mothers with DM 2 Pre-eclampsia (%) 9. 8 20. 0 Low birth weight (%) 18. 0 12. 0 Polyhydramnios (%) 23. 8 0 Pre-term labor (%) 29. 5 12. 0 Miscarriage (%) 2. 5 12. 0 Stillbirth (%) 2. 5 0 Peripartum hemorrhage (%) 16. 4 0 Infection (%) 1. 6 0 None (%) 35. 2 56. 0

Pregnancy Outcome 1 st pregnancy 2 nd and greater pregnancy Child has myotonic dystrophy

Pregnancy Outcome 1 st pregnancy 2 nd and greater pregnancy Child has myotonic dystrophy 47% yes, 28. 2% unsure 30. 9 yes, 38% unsure Neonatal complications in Mothers with DM 1 Breathing problems 33. 1 5. 5 Needed ventilator 25. 4 5. 2 Feeding problems 33. 6 6. 0 Needed a feeding tube 36. 1 6. 0 Hypotonia 32. 8 7. 4 Clubfoot 14. 8 3. 0

Pregnancy does not affect overall DM quality of life • Change not significant •

Pregnancy does not affect overall DM quality of life • Change not significant • Subgroup analysis did not identify increased scores with DM type, age, number of pregnancies, ART, or presence of affected child 16 Average MDHI-SF Score 14 12 10 8 6 4 2 0 Prior Pregnancy During Pregnancy After Pregnancy

6 mo prior *=p value <0. 05 am In b ab or a ula

6 mo prior *=p value <0. 05 am In b ab or a ula ilit rm tio yt pr n* o do oble ac ms tiv iti es F Ga at * igu st ro e* in te st Pai Co in n m m Visi al I * un on ss ica p ue tio rob s n le De d S iff ms le cr ep icu ea s i lti m De ed Em es p cr a s o a i ea tio rm t se isfa na en d c C t t pe i o li rfo on i gni ssue s* rm n s tiv an oci e is su ce al in situ es so a cia tio l s ns itu Ch Br a ok e in ath My ti. . . g o in o r s g d ton i w al iffic a l He owi ultie ar ng s in i s g d su iff es icu lti es nd ya nd Ha ilit ob M Impact Score Symptom Impact of Pregnancy in DM 1 and DM 2 2 1. 8 1. 6 1. 4 1. 2 1 0. 8 0. 6 0. 4 0. 2 0 Theme During 6 mo post

*=p value <0. 05 ilit ab or m bu am ar nd tio la

*=p value <0. 05 ilit ab or m bu am ar nd tio la yt pr n* o o do ble ac ms tiv iti es * Fa Ga tig st ue ro in te Pa st Co in al in m Vi m s I un ion ssu ica pr es tio ob le n m d Sle De iff s icu ep cr e l i De ase Em mp ties d cr ot airm ea sat io isf se na en ac d t pe tio Cog l iss u rfo n ni tiv es* rm in an soc e is ia su ce e in l sit ua s so ti cia l s ons itu at Ch Br i e ok M o. . . in ath g o in yoto ni rs gd a iff w icu al lo He wi lties ar ng i in g d ssu iff es icu lti es In ya nd Ha ilit ob M Impact Score Symptom Impact of Pregnancy in DM 1 2 1. 8 1. 6 1. 4 1. 2 1 0. 8 0. 6 0. 4 0. 2 0 Theme 6 mo prior During 6 mo post

yt Vi bu in al in Pa * ue tig es * s* m

yt Vi bu in al in Pa * ue tig es * s* m iti tiv Fa ac le n* tio la ob pr do m te st o ro in st un m Ga ilit ab ar am sio Iss u n ica pr es tio ob l Sle n d em De ep iffic s cr im ult e pa ies De ase E ir d m cr ot me ea sat n io isf se na t* ac d C pe t og l is su rfo ion n es rm in s itiv e o an ce cial issu es sit in u so cia atio n ls itu s at Ch Br io e ok M. . . a th in y ot g o in on g rs di ia w al fficu lo He win lties ar gi in g d ssu iff es icu lti es *=p value <0. 05 Co m In nd or ya nd Ha ilit ob M Impact Score Symptom Impact of Pregnancy DM 2 2 1. 8 1. 6 1. 4 1. 2 1 0. 8 0. 6 0. 4 0. 2 0 Theme 6 mo prior During 6 mo post

Conclusions • Increased rate of pregnancy complications in DM 1 and DM 2 •

Conclusions • Increased rate of pregnancy complications in DM 1 and DM 2 • High rate of potential congenital DM outcomes in respondents • Specific symptoms may worsen with pregnancy

Thank You • Supported by Myotonic Dystrophy Foundation • Collaborators – University of Utah

Thank You • Supported by Myotonic Dystrophy Foundation • Collaborators – University of Utah • Jeremy Franklin • Man Hung – University of Rochester • • Chad Heatwole Emma Ciafaloni Elizabeth Luebbe James Hilbert – Stanford University • Katherine Hagerman • John Day – Myotonic Dystrophy Foundation • Eriko Nasser